AU2012211969B2 - Polyphenol production by Vaccinium myrtillus cell cultures - Google Patents

Polyphenol production by Vaccinium myrtillus cell cultures Download PDF

Info

Publication number
AU2012211969B2
AU2012211969B2 AU2012211969A AU2012211969A AU2012211969B2 AU 2012211969 B2 AU2012211969 B2 AU 2012211969B2 AU 2012211969 A AU2012211969 A AU 2012211969A AU 2012211969 A AU2012211969 A AU 2012211969A AU 2012211969 B2 AU2012211969 B2 AU 2012211969B2
Authority
AU
Australia
Prior art keywords
cells
vaccinium myrtillus
dry mass
cell culture
comprised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2012211969A
Other languages
English (en)
Other versions
AU2012211969A1 (en
Inventor
Sonia Lall
Sung-Yong Yoon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dianaplantsciences SAS
Original Assignee
Dianaplantsciences SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dianaplantsciences SAS filed Critical Dianaplantsciences SAS
Publication of AU2012211969A1 publication Critical patent/AU2012211969A1/en
Assigned to DIANAPLANTSCIENCES, S.A.S. reassignment DIANAPLANTSCIENCES, S.A.S. Amend patent request/document other than specification (104) Assignors: DIANAPLANTSCIENCES S.A.S.
Application granted granted Critical
Publication of AU2012211969B2 publication Critical patent/AU2012211969B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/04—Plant cells or tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2012211969A 2011-02-04 2012-02-06 Polyphenol production by Vaccinium myrtillus cell cultures Expired - Fee Related AU2012211969B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161439675P 2011-02-04 2011-02-04
US61/439,675 2011-02-04
PCT/US2012/024008 WO2012106723A1 (en) 2011-02-04 2012-02-06 Polyphenol production by vaccinium myrtillus cell cultures

Publications (2)

Publication Number Publication Date
AU2012211969A1 AU2012211969A1 (en) 2013-08-15
AU2012211969B2 true AU2012211969B2 (en) 2016-04-21

Family

ID=46603117

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012211969A Expired - Fee Related AU2012211969B2 (en) 2011-02-04 2012-02-06 Polyphenol production by Vaccinium myrtillus cell cultures

Country Status (6)

Country Link
US (1) US20130323843A1 (enExample)
EP (1) EP2670247A4 (enExample)
JP (1) JP2014504651A (enExample)
CN (1) CN103459589A (enExample)
AU (1) AU2012211969B2 (enExample)
WO (1) WO2012106723A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6211380B2 (ja) * 2012-10-17 2017-10-11 丸善製薬株式会社 Ｔｉｅ２活性化剤、血管新生抑制剤、血管の成熟化剤、血管の正常化剤、及び血管の安定化剤
WO2014210391A1 (en) * 2013-06-26 2014-12-31 Dianaplantsciences, Inc. Incorporation of cultured bilberry cells in cosmetics, dietary supplements, and/or functional foods
CN104435078B (zh) * 2014-12-16 2018-11-16 汤臣倍健股份有限公司 一种组合物及其应用和制剂
US20180264060A1 (en) * 2017-03-15 2018-09-20 Tokiwa Phytochemical Co., Ltd. Composition for preventing, or precaution for dry eye
EP4461129A1 (en) 2023-05-09 2024-11-13 ZHAW - Zürcher Hochschule für Angewandte Wissenschaften Edible plant cell culture biomass based on fruit endocarp and/or seed explants and methods of its preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160054015A (ko) * 2009-04-03 2016-05-13 다이아나플랜트사이언스, 아이엔씨. 식물 세포 배양 유래 프로시아니딘의 생산 및 추출

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
D1 : MADHAVI ET AL: "Isolation of bioactive constituents from Vaccinium myrtillus (bilberry) fruits and cell cultures". Plant Science, 1998, vol. 131, pages 95-103 *
D2 : YAO ET AL: "Protective activities of Vaccinium antioxidants with potential relevance to mitochondrial dysfunction and neurotoxicity". NeuroToxicology, 2007, vol. 28, pages 93-100 *

Also Published As

Publication number Publication date
EP2670247A4 (en) 2014-09-24
AU2012211969A1 (en) 2013-08-15
WO2012106723A1 (en) 2012-08-09
US20130323843A1 (en) 2013-12-05
JP2014504651A (ja) 2014-02-24
CN103459589A (zh) 2013-12-18
EP2670247A1 (en) 2013-12-11

Similar Documents

Publication Publication Date Title
JP5789595B2 (ja) 植物の細胞培養物からのプロシアニジンの産生および抽出
Karam et al. Growth and rosmarinic acid accumulation in callus, cell suspension, and root cultures of wild Salvia fruticosa
US9167840B2 (en) Production and extraction of procyanidins from plant cell cultures
Yildirim et al. Effects of regeneration enhancers on micropropagation of Fragaria vesca L. and phenolic content comparison of field-grown and in vitro-grown plant materials by liquid chromatography-electrospray tandem mass spectrometry (LC–ESI-MS/MS)
Kumar et al. Influence of photoperiod on growth, bioactive compounds and antioxidant activity in callus cultures of Basella rubra L.
US8617621B2 (en) Composition for enhancing immunity containing plant stem cell line derived from cambium of Panax ginseng including wild ginseng or ginseng as an active ingredient
Vinothini et al. In vitro micropropagation, total phenolic content and comparative antioxidant activity of different extracts of Sesbania grandiflora (L.) Pers.
US20130323843A1 (en) Polyphenol production by vaccinium myrtillus cell cultures
Baskaran et al. In vitro propagation and biochemical changes in Aloe pruinosa
JP2023525203A (ja) インビトロ培養物のバイオマス由来の標準化植物抽出物、その調製方法及び使用
WO2007107803A2 (en) Process and modified media for preparing callus- and cell suspension cultures of hypericum perforatum l.
CN112996799A (zh) 包含来源于决明子芽的萘并吡喃酮衍生物的神经细胞保护用组合物
EP4037474A1 (en) Method for production of sterile flowering biomass in temporary immersion bioreactors
WO2019008225A1 (en) METHOD FOR PRODUCING BETULACEAE FAMILY CELL CULTURES, COMPOSITIONS COMPRISING THE CELL CULTURES AND USE OF THE CELL CULTURES
KR102678647B1 (ko) 블루베리로부터 비니페린 및 테로스틸벤을 대량생산하는 방법
Domínguez et al. Production of honokiol and magnolol in suspension cultures of Magnolia dealbata Zucc
Smith Vaccinium species (small-fruited berries): in vitro culture and the production of food colorants and phytochemicals
Bertoni et al. In vitro propagation and conservation of Zeyheria montana Mart: An endangered medicinal plant
Rodríguez-Sahagún et al. Efficient protocols for in vitro axillary bud proliferation and somatic embryogenesis of the medicinal plant Anemopsis californica
Tsalokostas Using tissue culture as an alternative source of polyphenols produced by Ficus carica L.
WO2025120640A1 (en) Cell cultured berries and products derived therefrom
Tocci Hypericum perforatum subsp. angustifolium: study of xanthone biosynthesis in planta and in in vitro systems
JP2006067945A (ja) アントシアニンの製造方法
EP4492967A1 (en) Biological method for decarboxylation of cannabinoids directly in plant tissues
Piovan et al. Somatic embryogenesis and glucosinolate/myrosinase system in vulnerable Brassica repanda subsp. glabrescens (Poldini) Gómez-Campo

Legal Events

Date Code Title Description
MK25 Application lapsed reg. 22.2i(2) - failure to pay acceptance fee